In our study, high levels of initial MxA were associated with severe disease in patients admitted for COVID-19 as depicted by higher level of IL-6 and lower initial oxygen saturation at presentation, and a higher need for respiratory support and for treatment with corticosteroids during hospitalization. Here, MX1 is linked to COVID-19.